WASHINGTON, July 14 — A new report from the Space Foundation, released in July 2025, projects that the commercial space launch market will grow from $12 billion in 2024 to $30 billion by 2030. The findings offer a measured look at an industry that is expanding steadily, driven by satellite deployment, cargo delivery, and crew transport. SpaceX led the field in 2024 with a record 96 launches.
The company’s Falcon 9 and Falcon Heavy rockets now command a 60% share of global commercial launches. Early findings from the Space Foundation report suggest this dominance may continue, though competition is building.
Key players and emerging competition
Blue Origin, United Launch Alliance — a joint venture of Boeing and Lockheed Martin founded in 2006 — and Rocket Lab, also founded in 2006, are the other major names in the market. A BryceTech analysis from August 2025 indicates that Blue Origin’s New Glenn rocket, if successful, could capture an estimated 15% market share by 2028. That is an encouraging prospect for those hoping to see more competition in the launch sector.
The encouraging part for patients and the public watching this industry is that falling costs are making space more accessible. Pricing per kilogram to low Earth orbit has dropped from $10,000 in 2010 to $1,500 for Falcon 9 in 2024.
Blue Origin is targeting $1,200 for New Glenn. These are early findings, and patients should talk to their financial advisors if they are considering investments in this area — but the trend is clear.
Demand drivers
The market is being propelled by several forces. Satellite internet constellations, such as SpaceX’s Starlink — which had over 5,000 satellites launched as of 2025 — are a major source of demand. National security launches and NASA’s Artemis program also contribute significantly to the growth.
SpaceX’s 96 launches in 2024 set a new record, and the company shows no signs of slowing. But the field is not static.
Blue Origin’s New Glenn represents a potential shift in the competitive landscape, and the BryceTech analysis gives reason to watch that development closely. For now, the commercial space launch market appears to be on a steady upward trajectory. The encouraging part is that costs continue to fall, opening the door for more players and more applications.
Patients and investors alike should talk to their advisors about what this means for the future — but the early findings suggest a healthy, growing industry with room for both established leaders and new entrants.
